What are the key recommendations and treatment approaches for common gynaecological issues such as polycystic ovary syndrome (PCOS), endometriosis, and urinary tract infections (UTIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Common Gynaecological Conditions: PCOS, Endometriosis, and Recurrent UTIs

Polycystic Ovary Syndrome (PCOS)

Diagnostic Approach

Screen all women with PCOS for type 2 diabetes using a fasting glucose followed by a 2-hour glucose tolerance test with 75-gram glucose load, and obtain a fasting lipid profile including total cholesterol, LDL, HDL, and triglycerides. 1, 2

  • Measure total testosterone or bioavailable/free testosterone levels to assess ovarian hyperandrogenism 1
  • Check thyroid-stimulating hormone and prolactin levels to exclude other causes of menstrual irregularity 1
  • Calculate body mass index and waist-hip ratio to assess metabolic risk 1, 2

Treatment Based on Reproductive Goals

For Women NOT Attempting to Conceive

Combined oral contraceptive pills are first-line therapy, as they suppress ovarian androgen secretion, increase sex hormone binding globulin, and reduce endometrial cancer risk. 1, 2, 3

  • Alternative: Medroxyprogesterone acetate (depot or intermittent oral) suppresses circulating androgen and pituitary gonadotropin levels 1
  • For hirsutism specifically: Combine an antiandrogen (spironolactone) with oral contraceptives for optimal effect 3
  • Topical eflornithine hydrochloride cream is the only FDA-approved topical treatment for hirsutism 1, 3

For Women Attempting to Conceive

Start with weight loss (minimum 5% of body weight) and regular exercise, then use clomiphene citrate as first-line pharmacological treatment—approximately 80% will ovulate and half will conceive. 1, 2, 3

  • If clomiphene fails, use low-dose gonadotropin therapy rather than high-dose to minimize ovarian hyperstimulation risk 1, 2, 3
  • Metformin improves ovulation frequency but its effects on early pregnancy are not well established 1, 3

Metabolic Management

Prescribe weight loss with an energy deficit of 30% or 500-750 kcal/day (1,200-1,500 kcal/day total), as even 5% weight loss significantly improves metabolic and reproductive abnormalities. 3

  • Recommend minimum 150 minutes/week of moderate intensity exercise, even without weight loss 3
  • Use metformin to improve insulin sensitivity and reduce diabetes/cardiovascular disease risk factors 1, 2
  • No specific diet type has proven superior; follow general healthy eating principles 3

Long-term Monitoring

  • Screen regularly for metabolic abnormalities and assess mental health, as PCOS patients have higher rates of depression, anxiety, and eating disorders 2
  • Monitor for cardiovascular disease risk factors, though oral contraceptive use does not increase cardiovascular events in PCOS compared to the general population 1

Endometriosis

Diagnosis

Only an experienced surgeon familiar with the varied appearances of endometriosis should rely on visual inspection alone; otherwise, obtain histologic examination to confirm endometrial lesions, especially those with nonclassical appearance. 1

  • Peritoneal biopsy should be used for questionable peritoneal lesions 1
  • Serum CA-125 has limited utility, especially in mild or minimal disease 1
  • Pain severity correlates with depth of lesions, not lesion type; painful lesions involve peritoneal surfaces innervated by peripheral spinal nerves 1

Medical Management for Pain

For pain relief, treat with a GnRH agonist for at least 3 months or danazol for at least 6 months—both are equally effective in most women. 1

  • When continuing GnRH agonist therapy, add add-back therapy to reduce or eliminate bone mineral loss without reducing pain relief efficacy 1
  • Oral contraceptives and oral or depot medroxyprogesterone acetate are effective compared to placebo and may be equivalent to more costly regimens 1
  • Progestins, NSAIDs, and GnRH agonists all reduce lesion size, but no medical therapy eradicates lesions 1
  • GnRH agonist therapy is appropriate for chronic pelvic pain even without surgical confirmation of endometriosis, if initial evaluation excludes other causes 1

Surgical Management

  • Surgery provides significant pain reduction in the first 6 months, but up to 44% experience symptom recurrence within one year 1
  • For severe endometriosis, medical treatment alone may not be sufficient 1
  • Hormone replacement therapy with estrogen is not contraindicated following hysterectomy and bilateral salpingo-oophorectomy for endometriosis 1

Fertility Considerations

  • No evidence proves that medical treatment affects future fertility in women with endometriosis 1
  • With minimal and mild endometriosis, a cause-and-effect relationship with infertility has not been proven 1
  • Studies lack evidence that absence of treatment is associated with fertility decline 1
  • For asymptomatic patients, expectant management may be appropriate as endometriosis is unpredictable and may regress 1

Recurrent Urinary Tract Infections (rUTIs)

Definition and Approach

Use an algorithmic approach based on patient population: postmenopausal women, premenopausal women with sexually-associated infections, or premenopausal women with non-sexually-associated infections. 1

Treatment by Population

Postmenopausal Women

Use vaginal estrogen with or without lactobacillus-containing probiotics as first-line prevention. 1

Premenopausal Women with Sexually-Associated rUTIs

Prescribe low-dose post-coital antibiotics. 1

Premenopausal Women with Non-Sexually-Associated rUTIs

Prescribe low-dose daily antibiotic prophylaxis. 1

Non-Antibiotic Alternatives

  • Methenamine hippurate and/or lactobacillus-containing probiotics can be used as non-antibiotic alternatives 1
  • Education on lifestyle and behavioral modifications should be provided to all patients 1

Important Caveats

  • The definition of rUTI is 2 or more symptomatic episodes in 6 months or 3 episodes in 1 year 1
  • Between 20-30% of women with one UTI will have recurrence, and 25% of these will have subsequent recurrent episodes 1
  • No multi-targeted treatment approach has been studied, and high-quality evidence for prevention strategies is lacking 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of PCOS

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.